**Abstract**

Depression is one of the most serious psychological disorders, but its pathogenesis remains unclear and the current medical treatment is mainly restrictive effect. We have identified Shati/Nat8l, which is containing a well-conserved *N*-acetyltransferase sequence, in the brain of psychosis animal model. Shati/Nat8l synthesizes *N*-acetylaspartate (NAA) from L-aspartate and acetyl-CoA, and NAA is subsequently converted into *N*-acetylaspartylglutamate (NAAG) by being condensed with glutamate. It is reported that NAA and NAAG abundantly exist in human brains and those both or one quantity change in the postmortem brain of patients with psychological disorders including depression. In the present study, to clarify the functional roles of Shati/Nat8l in depression, we investigated various behavioral analyses in Shati/Nat8l-overexpressed mice.

Firstly, the expression levels of Shati/Nat8l mRNA were assessed in the brain of depressed C57BL6J mouse model, which was exposed repeated social defeat stress for 10 days following procedure as physical stress for 10 min and sensory stress for 24 hrs by aggressor ICR mice. And, Shati/Nat8l mRNA in the dorsal striatum of the depression mice significantly increased compared with that of control mice. Therefore, mice were microinjected Shati/Nat8l-inserted or non-inserted (Mock) adeno-associated virus vectors into the dorsal striatum. The Shati/Nat8l-overexpressed mice exhibited decreased social interaction and sucrose preference after subthreshold social defeat stress as the exposure to aggressor ICR mice for 5 min×3 on only one day,which showed normal behaviors in the Mock mice. These two phenotypical impairments in the Shati/Nat8l-overexpressed mice were ameliorated by treatment with a selective serotonin reuptake inhibitor fluvoxamine at the dose of 10 mg/kg i.p., which has no effect in the Mock mice.

These findings suggest that Shati/Nat8l in the striatum play an important role in depression-like behaviors including diminished sociability and pleasure by regulating the serotonergic neuronal system.
